Health Care Equipment & Services

VentriPoint Diagnostics highlights unseen U.S. cardiovascular market shifts, offering investors insight into future growth and strategic opportunities in cardiac tech.

Sanuwave Health Q1 2026 revenue climbs 3‑4 % to $9.6‑9.7 M, showing steady growth amid a niche shock‑wave tech focus and investor caution.

Axogen Inc. announces Q1‑2026 results on April 28, detailing nerve‑repair growth, market performance, and an investor call to discuss future strategies.

Profound Medical Corp gears up for Q1 2026 results, spotlighting AI‑powered, incision‑free prostate therapy that promises precision and fewer side‑effects, while engaging investors to gauge future revenue growth and market acceptance.

Discover how Aclarion’s patented AI platform, Nociscan, transforms chronic low back pain care with 97% surgical success, cloud‑scalability, and industry awards.

MedMira Inc. promises next‑gen rapid diagnostics, yet faces steep financial hurdles—stock volatility, negative P/E and TSX Venture pressures highlight risks for investors seeking biotech gains.

QuidelOrtho Corp: Navigating financial challenges while driving diagnostic innovation—explore its market performance, tech focus, and future prospects.

Intuitive Surgical’s latest quarter shows 19% revenue growth and 16% profit boost, yet its high 58× P/E sparks debate as analysts split on future value.

Virax Biolabs’ new private placement injects capital into a biotech firm focused on viral diagnostics, PPE, and immunology—boosting shares and positioning it for growth in the healthcare sector.

Biomerica’s innovative focus on early chronic disease diagnostics, orthodontic gear, and allergy treatments promises better patient outcomes and lower health costs—yet investors watch its financial hurdles.